Forecast: Diabetes Medicine Use in Sweden

The data on diabetes medicine usage in Sweden reveals a consistent upward trend from 2013 through 2023. The growth was gradual from 2013 to 2020, with annual increases mainly ranging from about 1.62% to 4.47%. A significant surge was observed in 2022, where the year-on-year variation reached nearly 10%, with a Value standing at 80.5 Units per Thousand Persons per Day in 2023. Over the last five years, the compound annual growth rate (CAGR) has averaged 5.62%.

Between 2022 and 2023, the use of diabetes medicine continued to rise significantly, marking an approximately 6% increase. Looking ahead, the forecasts from 2024 to 2028 suggest a continued increase at a slightly lower CAGR of 3.22%, culminating in a total growth of 17.17% over this period.

Future trends to watch for include:

• Potential impacts of new diabetes medications and technologies.
• The influence of public health initiatives aimed at diabetes prevention and management.
• Demographic changes such as aging population and their effect on diabetes prevalence.
• Economic factors and healthcare policy changes impacting medicine affordability and accessibility.